Serum lipids and smoking status in coronary heart disease patients treated with simvastatin
Aim. To study the effectiveness of generic simvastatin in hyperlipidaemia (HLP) correction (isolated hypercholesterolemia, HCH, or HCH combined with hypertriglyceridemia, HTG) in patients with confirmed diagnosis of coronary heart disease (CHD), in regard to their smoking status. Material and method...
Saved in:
| Main Authors: | L. R. Gazdanova, V. A. Metelskaya, I. E. Koltunov, N. M. Akhmedzhanov, E. B. Yarovaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2010-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2036 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01) -
EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01) -
Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysisResearch in context
by: Deborah Keng Wai Yow, et al.
Published: (2025-06-01) -
A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA
by: V. P. Voronina, et al.
Published: (2016-01-01) -
Atorvastatin and simvastatin in clinical management of high-risk patients
by: S. A. Shalnova, et al.
Published: (2009-02-01)